Skip to main content

Histopathologie des Endometriumkarzinoms

Histopathology of endometrial carcinoma

Zusammenfassung

Das Endometriumkarzinom ist ein häufiger Tumor mit vielen histopathologischen Varianten. Die meisten Fälle werden als Typ-I-Tumoren klassifiziert, zeigen eine endometrioide Morphologie, sind von niedrigem Grad und Stadium, und die Fünfjahresüberlebensrate ist ausgezeichnet. Typ-II-Tumoren sind viel seltener, es handelt sich hauptsächlich um seröse Karzinome, und die Typ-II-Tumoren sind ohne Ausnahme hoch aggressiv. Die klinische Zweiteilung zeigt sich auch anhand der reproduzierbaren molekulargenetischen Alterationen, die für jeden Typ spezifisch sind. Über die den Typ-II-Tumoren zugrunde liegenden Genmutationen ist weniger bekannt, und es bleibt abzuwarten, ob die Klarzellkarzinome des Endometriums als Typ I oder II eingestuft werden können oder ob sie sich dieser Klassifikation weiterhin entziehen.

Abstract

Endometrial carcinoma is a common malignancy with numerous histopathologic variants. The majority of cases are classified as type I tumors, show endometrioid morphology, are low grade and low stage and have excellent 5-year survival. Type II tumors are much less common, are predominantly serous carcinomas and are uniformly highly aggressive. This clinical dichotomy is reflected in and supported by reproducible molecular genetic alterations specific to each type. Less is known about the underlying genetic mutations for the rarer type II tumors and it is yet to be determined if clear cell carcinoma of the endometrium will be classifiable as type I, type II or will remain an outlier in this classification.

This is a preview of subscription content, access via your institution.

Abb. 1
Abb. 2

Literatur

  1. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17

    Article  CAS  PubMed  Google Scholar 

  2. Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444:213–223

    Article  CAS  PubMed  Google Scholar 

  3. Baak JP, Kurver PH, Diegenbach PC et al (1981) Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy – a feasibility study. Histopathology 5:61–68

    Article  CAS  PubMed  Google Scholar 

  4. Mutter GL (2000) Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 76:287–290

    Article  CAS  PubMed  Google Scholar 

  5. Mutter GL, Zaino RJ, Baak JP et al (2007) Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 26:103–114

    Article  PubMed  Google Scholar 

  6. Lacey JV Jr, Mutter GL, Nucci MR et al (2008) Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 113:2073–2081

    Article  PubMed  Google Scholar 

  7. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104

    Article  PubMed  Google Scholar 

  8. Silverberg S, Kurman RJ, Nogales F et al (2003) Tumours of the uterine corpus. Epithelial tumours and related lesions. In: Tavassoli F, Devilee P (eds) World Health Organization Classification of tumours, pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon

  9. Benedet JL, Bender H, Jones H III et al (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262

    Article  CAS  PubMed  Google Scholar 

  10. Mutter GL, Lin MC, Fitzgerald JT et al (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–930

    Article  CAS  PubMed  Google Scholar 

  11. Levine RL, Cargile CB, Blazes MS et al (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258

    CAS  PubMed  Google Scholar 

  12. Maxwell GL, Risinger JI, Gumbs C et al (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500–2503

    CAS  PubMed  Google Scholar 

  13. Yoshinaga K, Sasano H, Furukawa T et al (1998) The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn J Cancer Res 89:985–990

    CAS  PubMed  Google Scholar 

  14. Ambros RA, Sherman ME, Zahn CM et al (1995) Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26:1260–1267

    Article  CAS  PubMed  Google Scholar 

  15. Sherman ME, Bitterman P, Rosenshein NB et al (1992) Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16:600–610

    Article  CAS  PubMed  Google Scholar 

  16. Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268–1274

    Article  CAS  PubMed  Google Scholar 

  17. Tashiro H, Isacson C, Levine R et al (1997) p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150:177–185

    CAS  PubMed  Google Scholar 

  18. Jia L, Liu Y, Yi X et al (2008) Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res 14:2263–2269

    Article  CAS  PubMed  Google Scholar 

  19. Liang SX, Chambers SK, Cheng L et al (2004) Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol 12:319–331

    Article  CAS  PubMed  Google Scholar 

  20. Zheng W, Liang SX, Yu H et al (2004) Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol 12:207–223

    Article  PubMed  Google Scholar 

  21. Silva EG, Deavers MT, Bodurka DC et al (2006) Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 25:52–58

    Article  PubMed  Google Scholar 

  22. Silva EG, Deavers MT, Malpica A (2007) Undifferentiated carcinoma of the endometrium: a review. Pathology 39:134–138

    Article  PubMed  Google Scholar 

  23. George E, Lillemoe TJ, Twiggs LB et al (1995) Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol 14:39–44

    CAS  PubMed  Google Scholar 

  24. Ferguson SE, Tornos C, Hummer A et al (2007) Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31:1653–1661

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R.J. Kurman M.D..

Zusatzmaterial online

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kurman, R., McConnell, T. Histopathologie des Endometriumkarzinoms. Onkologe 15, 1239–1242 (2009). https://doi.org/10.1007/s00761-009-1728-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-009-1728-7

Schlüsselwörter

Keywords